Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

428
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
428

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of Liner Dissociation and All-Cause Revision With Uncemented Acetabular Components in Primary Total Hip Arthroplasty.

The Journal of arthroplasty·2025
Same author

Synthetic Lubrication of Bone Interfaces for Late-Stage Osteoarthritis Treatment.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

A Quantitative Model of Chemotherapeutic Drug Sensitivity as a Function of P-Glycoprotein Expression.

Molecules (Basel, Switzerland)·2025
Same author

Programmable protein degraders enable selective knockdown of pathogenic β-catenin subpopulations <i>in vitro</i> and <i>in vivo</i>.

bioRxiv : the preprint server for biology·2024
Same author

Intranasal Vaccination with Recombinant TLR2-Active Outer Membrane Vesicles Containing Sequential M2e Epitopes Protects against Lethal Influenza a Challenge.

Vaccines·2024
Same author

Arthroplasty for Treating Proximal Femur Metastatic Lesions May Be Associated with Lower Mortality Rates Compared to Intramedullary Nailing within the VA Healthcare System.

Journal of clinical medicine·2023

Related Experiment Video

Updated: Sep 27, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

Biological Nanoparticles in Vaccine Development.

Stephanie M Curley1, David Putnam1,2

  • 1Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, United States.

Frontiers in Bioengineering and Biotechnology
|April 11, 2022
PubMed
Summary
This summary is machine-generated.

Biologically derived nanoparticles offer a promising new vaccine platform. These novel platforms leverage natural pathogen signals, reducing the need for artificial adjuvants and simplifying manufacturing for improved vaccine development.

Keywords:
OMVVLPnanoparticlesprotein cagesvaccines

More Related Videos

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.4K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K

Related Experiment Videos

Last Updated: Sep 27, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.4K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K

Area of Science:

  • Nanotechnology and Vaccine Development
  • Biotechnology and Public Health

Background:

  • Vaccines are a cornerstone of global public health, yet gaps remain for many infectious diseases.
  • Emerging infectious diseases and diseases without current vaccines necessitate innovative technological solutions.
  • Nanoscale platforms, exemplified by mRNA vaccines, show significant promise for vaccine delivery.

Purpose of the Study:

  • To review the current state of biologically derived nanoparticles as novel vaccine platforms.
  • To highlight the advantages of biological nanoparticles over synthetic alternatives in vaccine development.
  • To explore the potential of these platforms for addressing unmet needs in infectious disease prevention.

Main Methods:

  • Review of existing literature on biologically derived nanoparticles for vaccine applications.
  • Analysis of the properties and advantages of biological nanoparticles, including PAMPs and self-assembly.
  • Comparison of biological nanoparticle platforms with synthetic nanoscale delivery systems.

Main Results:

  • Biologically derived nanoparticles possess inherent pathogen-associated molecular patterns (PAMPs), potentially reducing reliance on artificial adjuvants.
  • These nanoparticles offer desirable characteristics such as biodegradability, biocompatibility, and self-assembly capabilities.
  • Self-assembly facilitates straightforward scalability for manufacturing from laboratory to industrial levels.

Conclusions:

  • Biologically derived nanoparticles represent a powerful and versatile platform for next-generation vaccines.
  • Their inherent biological properties and manufacturing advantages position them as a key area for future vaccine research.
  • Further development of these platforms could significantly advance the field of vaccinology for both existing and emerging threats.